The present invention relates to aryl substituted carboxamide derivatives of formula (I) or a pharmaceutically acceptable salt thereof, which have blocking activities of T-type calcium channels or voltage gated sodium channels as the tetrodotoxin-sensitive (TTX-S)blockers such as NaV1.3 and NaV1.7, and which are useful in the treatment or prevention of disorders and diseases in which T-type calcium channels or voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which T-type calcium channels or voltage gated sodium channels are involved.
本发明涉及式(I)或其药物可接受的盐的芳基取代羧酰胺衍
生物,其具有T型
钙通道或电压门控
钠通道的阻断活性,如NaV1.3和NaV1.7等Tetrodotoxin敏感(
TTX-S)阻断剂,适用于治疗或预防涉及T型
钙通道或电压门控
钠通道的疾病和紊乱。本发明还涉及包含这些化合物的药物组合物以及在预防或治疗涉及T型
钙通道或电压门控
钠通道的疾病中使用这些化合物和组合物的用途。